- Advertisement -
Friday, September 25, 2020
33.5 C
Delhi
Home Latest News BANGLADESH WILL GET HIGH PRIORITY IN SUPPLY OF COVID VACCINE: MEA SPOKESPERSON...

BANGLADESH WILL GET HIGH PRIORITY IN SUPPLY OF COVID VACCINE: MEA SPOKESPERSON ANURAG SHRIVASTAVA

India has reiterated once again that when it comes to the COVID vaccine, Bangladesh will get a priority. 

image courtesy zee news

New Delhi: India has reiterated once again that when it comes to the COVID vaccine, Bangladesh will get a priority. The issue of the coronavirus vaccine was discussed during Indian Foreign Secretary Harsh Vardhan Shringla’s visit to Dhaka.

“As a close neighbour and strategic partner, we have assured the Bangladesh side that Bangladesh will get high priority in supply of vaccine, once ready. We are glad to note that enterprises on both sides are also taking steps towards this end,” said the Ministry of External Affairs spokesperson Anurag Shrivastava in his weekly presser.

The issue of the COVID-19 vaccine was discussed during Indian Foreign Secretary Harsh Vardhan Shringla to Dhaka. 

Days after Harsh Vardhan Shringla’s visit to Dhaka, Bangladesh’s largest pharma company Beximco Pharmaceuticals announced that it is investing in the Serum Institute of India for the vaccine.

Issuing a statement, the company said, “Once the vaccine receives regulatory approvals, SII will include Bangladesh among the countries who will be the first to receive an agreed quantity” of the COVID vaccine. 

India currently produces over 60% of the world’s vaccine and amidst the COVID pandemic supplied hydroxychloroquine and paracetamol to over 100 countries. 

Three COVID vaccines are currently in different stages of development and India is expected to start mass production after the regulatory approval. India has sent medicines to Bangladesh and has also been conducting capacity building courses.

news credit zee news

- Advertisement -

Subscribe to our newsletter

To be updated with all the latest news,

- Advertisement -

Stay Connected

8,000FansLike
2,458FollowersFollow
61,453SubscribersSubscribe

Must Read

NCB SUMMONS DEEPIKA PADUKONE, SHRADDHA KAPOOR, SARA ALI KHAN, RAKUL PREET SINGH IN DRUGS CASE

Today, the NCB probed Sushant’s former manager and KWAN employee Jaya Saha, director of the management agency, producer Madhu Mantena. 
- Advertisement -

US, UAE EYE DECEMBER GOAL TO AGREE ON F-35 DEAL, SAY SOURCES

Sources close to the negotiations said the goal is to have a letter of agreement in place in time for UAE National...

IMD PREDICTS VERY HEAVY RAINFALL IN WEST BENGAL, ASSAM, UTTAR PRADESH AND BIHAR OVER NEXT FEW DAYS

A low-pressure area lies over central parts of west Madhya Pradesh and neighbourhood with associated cyclonic circulation extending up to mid-tropospheric levels.

CORONAVIRUS CAME FROM A LAB ON PURPOSE, SAYS CHINESE VIROLOGIST DR LI-MENG YAN

On being asked whether she thought that the Chinese government could influence studies and research on COVID-19, Dr Li-Meng Yan said “Of...

Related News

NCB SUMMONS DEEPIKA PADUKONE, SHRADDHA KAPOOR, SARA ALI KHAN, RAKUL PREET SINGH IN DRUGS CASE

Today, the NCB probed Sushant’s former manager and KWAN employee Jaya Saha, director of the management agency, producer Madhu Mantena. 

US, UAE EYE DECEMBER GOAL TO AGREE ON F-35 DEAL, SAY SOURCES

Sources close to the negotiations said the goal is to have a letter of agreement in place in time for UAE National...

IMD PREDICTS VERY HEAVY RAINFALL IN WEST BENGAL, ASSAM, UTTAR PRADESH AND BIHAR OVER NEXT FEW DAYS

A low-pressure area lies over central parts of west Madhya Pradesh and neighbourhood with associated cyclonic circulation extending up to mid-tropospheric levels.

CORONAVIRUS CAME FROM A LAB ON PURPOSE, SAYS CHINESE VIROLOGIST DR LI-MENG YAN

On being asked whether she thought that the Chinese government could influence studies and research on COVID-19, Dr Li-Meng Yan said “Of...

RUSSIA TO REGISTER SECOND CORONAVIRUS VACCINE BY OCTOBER 15

The vaccine has been developed by Siberia’s Vector Institute, which completed early-stage human trials of the vaccine last week.
- Advertisement -